Search results for "44"

showing 10 items of 1507 documents

"2/NPART*VS" of "Centrality and pseudorapidity dependence of the charged-particle multiplicity density in Xe-Xe collisions at $\sqrt{s_{\rm NN}}$ = 5…

2019

Values of $2/\langle N_\mathrm{part} \rangle \langle \mathrm{d}N_\mathrm{ch}/\mathrm{d}\eta\rangle$ and $2/\langle N_\mathrm{part} \rangle N^\mathrm{tot}_\mathrm{ch}$ as a function of $\langle N_\mathrm{part} \rangle$ in Xe--Xe collisions at $\sqrt{s_{_{\mathrm{NN}}}} = 5.44\,\mathrm{TeV}$.

Nonlinear Sciences::Chaotic DynamicsMathematics::Functional AnalysisMathematics::Group TheoryHigh Energy Physics::LatticeHigh Energy Physics::Phenomenology5440.0XE XE --> CHARGED X2/NPART*
researchProduct

s-wave pion-nucleus optical potential

2007

We calculate the s-wave part of the pion-nucleus optical potential using a unitarized chiral approach that has been previously used to simultaneously describe pionic hydrogen and deuterium data as well as low energy pi N scattering in the vacuum. This energy dependent model allows for additional isoscalar parts in the potential from multiple rescattering. We consider Pauli blocking and pion polarization in an asymmetric nuclear matter environment. Also, higher order corrections of the pi N amplitude are included. The model can accommodate the repulsion required by phenomenological fits, though the theoretical uncertainties are bigger than previously thought. At the same time, we also find a…

Nuclear and High Energy PhysicsParticle physicsscattering amplitude [pi nucleon]Nuclear Theorymedia_common.quotation_subjectIsoscalarpartial waveNuclear TheoryFOS: Physical sciencesAsymmetryrenormalizationNuclear physicsNuclear Theory (nucl-th)symbols.namesakePionPauli exclusion principlemesic atom [deuterium]unitarityddc:530higher-order [Feynman graph]nuclear reaction [pi nucleus]numerical calculationsNuclear Experimentmedia_commonPhysicschiral [symmetry]UnitarityIsovectorN(1440)FísicaNuclear mattermesic atom [hydrogen]propagator [pi]Scattering amplitudenuclear mattersymbolsoptical [potential]correction [vertex function]
researchProduct

Salute e lavoro in un'ottica di genere

2017

E' stata condotta una revisione della letteratura per evidenziare quali tra le patologie lavoro-correlate esprimano differenze di sesso/genere negli outcome di salute e focalizzare i principali limiti degli studi in tale ambito. La ricerca, effettuata su PubMed mediante stringa specifica, ha identificato 4828 articoli (periodo 1997-2017) di cui 381 eleggibili ai fini della revisione (4-22% a seconda della patologia). Tra questi, il 68% hanno evidenziato differenze di sesso/genere negli outcome di salute che nella maggior parte dei casi sembrano dovute ad una diversa esposizione e/o ad una segregazione lavorativa, piuttosto che a differenze biologiche. Pochi studi tuttavia pongono tale valut…

Occupational healthSettore MED/44 - Medicina Del LavoroEnvironmental and Occupational HealthSexlgender differencePublic HealthOccupational health; Sexlgender difference; Work-related diseases; Public Health Environmental and Occupational HealthWork-related diseasesdifferenze di sesso/genere medicina del lavoro patologie lavoro-correlate
researchProduct

Direct Analysis of Psilocin and Muscimol in Urine Samples Using Single Drop Microextraction Technique In-Line with Capillary Electrophoresis

2020

The fully automated system of single drop microextraction coupled with capillary electrophoresis (SDME-CE) was developed for in-line preconcentration and determination of muscimol (MUS) and psilocin (PSC) from urine samples. Those two analytes are characteristic active metabolites of Amanita and Psilocybe mushrooms, evoking visual and auditory hallucinations. Study analytes were selectively extracted from the donor phase (urine samples, pH 4) into the organic phase (a drop of octanol layer), and re-extracted to the acidic acceptor (background electrolyte, BGE), consisting of 25 mM phosphate buffer (pH 3). The optimized conditions for the extraction procedure of a 200 &micro

OctanolAnalyteLiquid Phase MicroextractionCalibration curveAmanitacapillary electrophoresisPharmaceutical ScienceElectrolyteUrinesingle drop microextraction01 natural sciencesArticleAnalytical Chemistrylcsh:QD241-44103 medical and health scienceschemistry.chemical_compound0302 clinical medicineCapillary electrophoresislcsh:Organic chemistryLimit of DetectionDrug DiscoverymedicineHumans030216 legal & forensic medicinePhysical and Theoretical ChemistrypsilocinChromatographyChemistrygreen chemistry010401 analytical chemistryOrganic ChemistryElectrophoresis CapillaryHydrogen-Ion ConcentrationmuscimolurinePsilocybin0104 chemical sciencesDilutionChemistry (miscellaneous)PsilocinCalibrationHallucinogensSolventsMolecular MedicinePsilocybemedicine.drugMolecules
researchProduct

Tandem cross enyne metathesis (CEYM)–intramolecular Diels–Alder reaction (IMDAR). An easy entry to linear bicyclic scaffolds

2015

A new tandem cross enyne metathesis (CEYM)–intramolecular Diels–Alder reaction (IMDAR) has been carried out. It involves conjugated ketones, esters or amides bearing a remote olefin and aromatic alkynes as the starting materials. The overall process enables the preparation of a small family of linear bicyclic scaffolds in a very simple manner with moderate to good levels of diastereoselectivity. This methodology constitutes one of the few examples that employ olefins differently than ethylene in tandem CEYM–IMDAR protocols.

Olefin fiberBicyclic moleculeTandemChemistryOrganic ChemistryConjugated systemEnyne metathesisCombinatorial chemistryFull Research Paperlcsh:QD241-441Chemistrylcsh:Organic chemistryCascade reactionDiels–Alder reactionIntramolecular forcebicyclic frameworkscross enyne metathesisOrganic chemistrylcsh:Qtandem reactionlcsh:ScienceDiels-Alder reactionDiels–Alder reactionBeilstein Journal of Organic Chemistry
researchProduct

Characterization of lung tumourspheres reveals cancer stem-like cells potential targets and prognostic markers in non-small cell lung cancer

2019

Abstract Background Non-small cell lung cancer (NSCLC) is the first cause of death cancer-related worldwide mainly due to high therapeutic resistance. This resistance is related to cancer stem-like cells (CSCs), for which the identification of targets and markers is still ongoing. Methods Primary cultures from 8 NSCLC patients were established as tumorspheres and as monolayers. CSCs properties were tested for both conditions in vitro and in vivo. The expression of 50 CSCs-related genes was assessed by RTqPCR and proteins of significantly overexpressed genes were examined by immunoblot and immunofluorescence. The prognostic role of these genes was analyzed in a cohort of 661 NSCLC patients f…

OncologyHomeobox protein NANOGmedicine.medical_specialtybiologybusiness.industryCD44CancerHematologymedicine.diseaseOncologyInternal medicineCohortbiology.proteinmedicineAdenocarcinomaBiomarker (medicine)businessLung cancerITGA6Annals of Oncology
researchProduct

Clinical Translation and First In-Human Use of [44Sc]Sc-PSMA-617 for PET Imaging of Metastasized Castrate-Resistant Prostate Cancer

2017

Background: Various trivalent radiometals are well suited for labeling of DOTA-conjugated variants of Glu-ureido-based prostate-specific membrane antigen (PSMA) inhibitors. The DOTA-conjugate PSMA-617 has proven high potential in PSMA radioligand therapy (PSMA-RLT) of prostate cancer as well as PET imaging when labeled with lutetium-177 and gallium-68 respectively. Considering the relatively short physical half-life of gallium-68 this positron emitter precludes prolonged acquisition periods, as required for pre-therapeutic dosimetry or intraoperative applications. In this context, the positron emitter scandium-44 is an attractive alternative for PET imaging. We report the synthesis of [44Sc…

OncologyMalemedicine.medical_specialtytheranostics.Medicine (miscellaneous)Context (language use)SpleenGallium RadioisotopesLutetiumurologic and male genital diseases030218 nuclear medicine & medical imaging03 medical and health sciencesProstate cancerHeterocyclic Compounds 1-Ring0302 clinical medicineInternal medicinePositron Emission Tomography Computed TomographyLNCaPmedicineDosimetryHumansRadiometryPharmacology Toxicology and Pharmaceutics (miscellaneous)AgedRadioisotopesUrinary bladderChemistrybusiness.industryDipeptidesProstate-Specific Antigenmedicine.diseaseprostate cancerPSMA-617scandium-44Small intestineProstatic Neoplasms Castration-Resistantmedicine.anatomical_structurePET030220 oncology & carcinogenesisAbsorbed doseRadiopharmaceuticalsNuclear medicinebusinessScandiumResearch PaperHalf-LifeTheranostics
researchProduct

Cancer Stem Cell Biomarkers Predictive of Radiotherapy Response in Rectal Cancer: A Systematic Review

2021

Background: Rectal cancer (RC) is one of the most commonly diagnosed and particularly challenging tumours to treat due to its location in the pelvis and close proximity to critical genitourinary organs. Radiotherapy (RT) is recognised as a key component of therapeutic strategy to treat RC, promoting the downsizing and downstaging of large RCs in neoadjuvant settings, although its therapeutic effect is limited due to radioresistance. Evidence from experimental and clinical studies indicates that the likelihood of achieving local tumour control by RT depends on the complete eradication of cancer stem cells (CSC), a minority subset of tumour cells with stemness properties. Methods: A systemati…

OncologyNeo-adjuvant radiotherapymedicine.medical_specialtyColorectal cancermedicine.medical_treatmentReviewQH426-470RadiosensitivityCancer stem cellRadioresistanceInternal medicineBiomarkers TumorGeneticsmedicineHumansGenetics (clinical)Rectal cancer (RC)biologyRectal NeoplasmsCancer stem cellsGenitourinary systembusiness.industryCD44Therapeutic effectmedicine.diseaseOrganoidsRadiation therapyTreatment OutcomeSystematic reviewIn vitro radiotherapyNeoplastic Stem Cellsbiology.proteinbusinessGenes
researchProduct

Semi-Mechanistic Pharmacokinetic Model to Guide the Dose Selection of Nimotuzumab in Patients with Autosomal Dominant Polycystic Kidney Disease

2020

Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disease characterized by an overexpression of epidermal growth factor receptor (EGFR). Nimotuzumab is a recombinant humanized monoclonal antibody against human EGFR. The aim of this study was to develop a population pharmacokinetic model for nimotuzumab and to identify demographic and clinical predictive factors of the pharmacokinetic variability. The population pharmacokinetics (PopPK) of nimotuzumab was characterized using a nonlinear mixed-effect modeling approach with NONMEM&reg

Oncologymedicine.medical_specialtyEGFRPopulationAutosomal dominant polycystic kidney diseasePharmaceutical SciencePhases of clinical researchlcsh:RS1-441030226 pharmacology & pharmacyArticlesemi-mechanistic pharmacokineticslcsh:Pharmacy and materia medica03 medical and health sciences0302 clinical medicinePharmacokineticsInternal medicinepopulation analysismedicinePolycystic kidney diseaseNimotuzumabEpidermal growth factor receptoreducationNONMEMeducation.field_of_studybiologyautosomal dominant polycystic kidney diseasebusiness.industrynimotuzumabmedicine.diseaseNONMEM030220 oncology & carcinogenesisbiology.proteinbusinessmedicine.drugPharmaceutics
researchProduct

Expression and prognostic value of the CD44 splicing variants v5 and v6 in gastric cancer

1997

In the present study, the expression and prognostic role of the CD44 splicing variants v5 and v6 were immunohistochemically investigated in 418 curatively resected gastric carcinomas. CD44v5 was expressed in 65·3 per cent (n=273) and CD44v6 in 77·0 per cent (n=322) of the tumours. Whereas the expression of CD44v5 was correlated with advanced pT categories, with lymph node involvement, and with the presence of blood and lymphatic vessel invasion, such a correlation could not be found for the variant v6. As shown by univariate analysis, patients with CD44v5-positive tumours had a significantly shorter overall survival than patients with CD44v5-negative tumours (P=0·049). In contrast, expressi…

Oncologymedicine.medical_specialtyUnivariate analysisPathologybiologyStomachCD44Cancermedicine.diseasePathology and Forensic Medicinemedicine.anatomical_structureInternal medicinemedicineLymphatic vesselbiology.proteinAdenocarcinomaImmunohistochemistryLymph nodeThe Journal of Pathology
researchProduct